References
- Blesch G. Doing more with more? Hospitals face renewed calls for staffing mandates while dealing with recession-related workforce cuts. Mod. Healthc.39(21), 26–27 (2009).
- Willett MS, Bertch KE, Rich DS, Ereshefsky L. Prospectus on the economic value of clinical pharmacy services. A position statement of the American College of Clinical Pharmacy. Pharmacotherapy9(1), 45–56 (1989).
- Schumock GT, Meek PK, Ploetz PA, Vermeulen LC. Economic evaluations of clinical pharmacy services: 1988–1995. Pharmacotherapy16(6), 1188–1208 (1996).
- Schumock GT, Butler MG, Meek PD et al. Evidence of the economic benefit of clinical pharmacy services: 1996–2000. Pharmacotherapy23(1), 113–132 (2003).
- Perez A, Doloresco F, Hoffman JM et al. Economic evaluations of clinical pharmacy services: 2001–2005. Pharmacotherapy28(11), 285e–323e (2008).
- American College of Clinical Pharmacy. The definition of clinical pharmacy. Pharmacotherapy28(6), 816–817 (2008).
- Schumock G, Butler M. Evaluating and justifying clinical pharmacy services. In: Pharmacoeconomics & Outcomes (2nd Edition). Grauer DW, Lee J, Odom TD et al (Eds). American College of Clinical Pharmacy, MO, USA, 1–18 (2003).
- Pickard AS, Johnson JA, Farris KB. The impact of pharmacist interventions on health-related quality of life. Ann. Pharmacother.33(11), 1167–1172 (1999).
- Pickard AS, Hung S. An update on evidence of clinical pharmacy services’ impact on health-related quality of life. Ann. Pharmacother.40(9), 1623–1634 (2006).
- Wagner EH, Grothaus LC, Sandhu N et al. Chronic care clinics for diabetes in primary care: a system-wide randomized trial. Diabetes Care24(4), 695–700 (2001).
- Kaboli PJ, Hoth AB, McClimon BJ, Schnipper JL. Clinical pharmacists and inpatient medical care. Arch. Intern. Med.166(9), 955–964 (2006).
- De Rijdt T, Willems L, Simoens S. Economic effects of clinical pharmacy interventions: a literature review. Am. J. Health Syst. Pharm.65(12), 1161–1172 (2008).
- Hoffman JM, Meek PD, Touchette DR, Vermeulen LC, Schumock GT. Transparent and reproducible reports of economic evaluations of clinical pharmacy services: a goal for the future? Am. J. Health Syst. Pharm.66(5), 442–443 (2009).
- Bond CA, Raehl CL. Pharmacist-provided anticoagulation management in United States hospitals: death rates, length of stay, Medicare charges, bleeding complications, and transfusions. Pharmacotherapy24(8), 953–963 (2004).
- Bond CA, Raehl CL. Clinical and economic outcomes of pharmacist-managed antiepileptic drug therapy. Pharmacotherapy26(10), 1369–1378 (2006).
- Bond CA, Raehl CL. Clinical and economic outcomes of pharmacist-managed antimicrobial prophylaxis in surgical patients. Am. J. Health Syst. Pharm.64(18), 1935–1942 (2007).
- Lada P, Delgado G Jr. Documentation of pharmacists’ interventions in an emergency department and associated cost avoidance. Am. J. Health Syst. Pharm.64(1), 63–68 (2007).
- Kopp BJ, Mrsan M, Erstad BL, Duby JJ. Cost implications of and potential adverse events prevented by interventions of a critical care pharmacist. Am. J. Health Syst. Pharm.64(23), 2483–2487 (2007).
- Englesbe MJ, Pelletier SJ, Magee JC et al. Seasonal variation in surgical outcomes as measured by the American College of Surgeons-National Surgical Quality Improvement Program (ACS-NSQIP). Ann. Surg.246(3), 456–465 (2007).
- Pellegrino AN, Martin MT, Tilton JJ, Touchette DR. Medication therapy management services: definitions and outcomes. Drugs69(4), 393–406 (2009).
- Perez A. Evidence base for justification of clinical pharmacy services. Presented at: 2008 Annual Meeting of the American College of Clinical Pharmacy. KY, USA, 19–22 October 2008.
Websites
- Mapi Research Institute. PROQOLID, the Patient-Reported Outcome and Quality of Life Instruments Database. 2009 www.proqolid.org
- NIH Roadmap for Medical Research. Clinical outcomes assessment: PROMIS. 18 February 2009 http://nihroadmap.nih.gov/clinicalresearch/overview-dyn